Literature DB >> 6461457

Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo.

P Hersey, K Ho, J Werkmeister, U Abele.   

Abstract

The action of levamisole on immunoglobulin production was investigated in pokeweed mitogen-stimulated cultures of B and T cells. Immunoglobulin production was measured by nephelometric methods using specific antisera to IgA, IgG and IgM. Levamisole was shown to have no effect on B lymphocytes but pretreatment of T lymphocytes with levamisole resulted in an increase in immunoglobulin production which was maximal at 10(-6) M. The latter increase appeared to be due to an effect on suppressor T cells in that pretreatment of T cells depleted of suppressor cells (by irradiation or removal of T cells with receptors with IgG) did not result in an increase in immunoglobulin production. Similar effects of levamisole were demonstrated against suppressor cells induced by concanavalin A in vitro and against spontaneous suppressor cell activity in vivo. The effect of levamisole and irradiation on suppressor cell activity against particular classes of immunoglobulin varied between individuals. Suppressor cell activity against IgA production alone was demonstrated in six of 17 subjects whereas in the remainder, immunoglobulin classes. The implications of this action of levamisole for its effects in vivo are unknown, but the results appear consistent with many of the observed effects of the drug. Selection of patients with diseases associated with high suppressor cell activity may lead to more effective use of the drug.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6461457      PMCID: PMC1536399     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Characterization of mononuclear effector cells in human blood.

Authors:  P Hersey; A Edwards; J Edwards
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.

Authors:  B Ramot; M Biniaminov; C Shoham; E Rosenthal
Journal:  N Engl J Med       Date:  1976-04-08       Impact factor: 91.245

3.  Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels.

Authors:  J W Hadden; R G Coffey; E M Hadden; E Lopez-Corrales; G H Sunshine
Journal:  Cell Immunol       Date:  1975-11       Impact factor: 4.868

4.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

5.  Modulation of immune reactivity by phenylimidothiazole salts in mice immunized by sheep red blood cells.

Authors:  G Renoux; M Renoux
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

6.  Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer.

Authors:  D Tripodi; L C Parks; J Brugmans
Journal:  N Engl J Med       Date:  1973-08-16       Impact factor: 91.245

7.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

8.  In vitro reversal of cellular unresponsiveness induced by levamisole.

Authors:  H Golding; B Golding; R Jacobson; R Lomnitzer; H J Koornhof; A R Rabson
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

9.  The effect of levamisole on cellular immunity in multiple sclerosis.

Authors:  P C Dau; K P Johnson; L E Spitler
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

10.  Effects of levamisole on in vitro suppressosr cell function in normal humans and patients with systemic lupus erythematosus.

Authors:  A Rabson; S Blank; R Lomnitzer
Journal:  Immunopharmacology       Date:  1980-04
View more
  4 in total

1.  Immunoregulatory treatment for minimal change nephrotic syndrome.

Authors:  P F Miller
Journal:  Arch Dis Child       Date:  1986-07       Impact factor: 3.791

2.  Association of Sjögren's syndrome with C4 deficiency, defective reticuloendothelial function and circulating immune complexes.

Authors:  P Hersey; S Lawrence; D Prendergast; C Bindon; W Benson; P Valk
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

3.  Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia.

Authors:  Min Wang; Xingxin Li; Jun Shi; Yingqi Shao; Meili Ge; Jinbo Huang; Zhendong Huang; Jing Zhang; Neng Nie; Yizhou Zheng
Journal:  Int J Hematol       Date:  2015-06-14       Impact factor: 2.490

4.  Cellular immune responses in peripheral blood lymphocytes of Giardia infected squirrel monkey (Saimiri boliviensis boliviensis) treated with Fenbendazole.

Authors:  Pramod N Nehete; Gregory Wilkerson; Bharti P Nehete; Sriram Chitta; Julio C Ruiz; Henrieta Scholtzova; Lawrence E Williams; Christian R Abee; John A Vanchiere
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.